1-5 of 5
Sofia Paul
Close
Sort by
Journal Articles

Dreamm-5 Platform Trial: Belantamab Mafodotin (Belamaf) in Combination with Four Different Novel Agents in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Paul G. Richardson, MD, Ajay Nooka, MDMPH, Hang Quach, MDFRACP,FRCPA,MBBS, Suzanne Trudel, MD, David Routledge, Kevin Song, MD, Hareth Nahi, MD, Sofia Paul, Josephine Khan, Maria Brouch, Geraldine Ferron-Brady, PhD, Anne Yeakey, MD, Chris Shelton, Rocio Montes de Oca, PhD, L. Mary Smith, Ellie Im, Christoph M Ahlers, Elaine M Paul, Beata Holkova, Ira Gupta, MD, Brandon E. Kremer, MD PhD, Paula Rodriguez-Otero, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-139182
Published: 2020
Journal Articles

Efficacy and Safety Based on Duration of Treatment of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma in the Phase 3 Panorama 1 Study

Jesus San Miguel, MD PhD, Vania TM Hungria, Sung-Soo Yoon, MD PhD, Meral Beksac, MD, Meletios A. Dimopoulos, Ashraf Elghandour, MD, Wieslaw Wiktor Jedrzejczak, MD, Andreas Guenther, MD, Thanyaphong Na Nakorn, MD PhD, Noppadol Siritanaratkul, MD, Robert L Schlossman, MD, Jian Hou, MD PhD, Philippe Moreau, MD, Sagar Lonial, MD, Jae-Hoon Lee, Hermann Einsele, MD, Hans Salwender, MD, Monika Sopala, Suman Redhu, Sofia Paul, PhD, Claudia Corrado, Florence Binlich, Paul G. Richardson
Journal: Blood
Blood (2014) 124 (21): 4742.
https://doi.org/10.1182/blood.V124.21.4742.4742
Published: 2014
Journal Articles

Population Pharmacokinetics of Panobinostat (LBH589) in Patients with Advanced Solid Tumors and Hematologic Malignancies Following Intravenous and Oral Administration.

Marina Savelieva, Praz, Dr., sc., math., Margaret M. Woo, Harald A. Weber, MD, Samit Hirawat, MD, Sofia Paul, PhD, Joanne Schindler, Roland Fisch, PhD
Journal: Blood
Blood (2009) 114 (22): 3780.
https://doi.org/10.1182/blood.V114.22.3780.3780
Published: 2009
Journal Articles

QT Interval Measurements in Patients with Hematologic Malignancies and Solid Tumors Treated with Oral Panobinostat (LBH589).

Harald A. Weber, MD, Feng Tai, PhD, Sofia Paul, PhD, Joanne Schindler, Margaret M. Woo, Stan Spence, PhD, Jennifer Marlowe, Rong Lin, MD
Journal: Blood
Blood (2009) 114 (22): 3781.
https://doi.org/10.1182/blood.V114.22.3781.3781
Published: 2009
Journal Articles

Characteristics of Thrombocytopenia in Patients Treated with Oral Panobinostat (LBH589).

Rong Lin, MD, Jing Hu, PhD, Sofia Paul, PhD, Joanne Schindler, Margaret M. Woo, Stan Spence, PhD, Samit Hirawat, MD, Harald A. Weber, MD
Journal: Blood
Blood (2009) 114 (22): 2740.
https://doi.org/10.1182/blood.V114.22.2740.2740
Published: 2009